Dr. Paul E. Feuerstadt, MD

Dr. Feuerstadt practices at Endoscopy Center of Connecticut in Hamden, Connecticut.

Dr. Feuerstadt's NPI, 1386975928, was assigned on January 21, 2010. Dr. Feuerstadt graduated from Weill Cornell Medicine in 2004. Dr. Feuerstadt holds Connecticut license 48396.

Dr. Feuerstadt's primary practice is Endoscopy Center of Connecticut, at 2200 Whitney Avenue, Suite 380, Hamden, CT 06518. The practice phone is (203) 281-3636.

Dr. Feuerstadt's primary practice is Endoscopy Center of Connecticut in Hamden, Connecticut. Dr. Feuerstadt is also affiliated with Yale New Haven Hospital. The medical group on file is Northeast Medical Group. Dmand AI also links Dr. Feuerstadt to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Feuerstadt practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Feuerstadt's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Feuerstadt is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Feuerstadt's licenses on file in 3 states: Connecticut, New York and Florida.

Dmand AI lists acid reflux, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroenteritis, gastrointestinal bleeding and hemorrhoids among the conditions Dr. Feuerstadt treats.

CMS data shows 285 Medicare services from Dr. Feuerstadt across 7 procedure codes in 2024, for 213 Medicare patients. Medicare paid $27,468 for them.

CMS counts 213 Medicare patients who saw Dr. Feuerstadt in 2024. The largest group is 65 to 74, with 89 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Feuerstadt's median patient age at 62, with 54% women.

In 2024, Dr. Feuerstadt wrote 1,192 Medicare Part D claims for 308 patients. 81% of them were for generic drugs. CMS names the drug for 1,032 of them, across 22 drugs with 11 or more claims each, at $294,624 in total drug cost. In 2023, CMS named 1,073 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Feuerstadt for performance year 2024, reported through an alternative payment model (APM). Dr. Feuerstadt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Feuerstadt as offering telehealth. CMS counts 36 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Feuerstadt, more than 58% of the clinicians it reports for that procedure.

Dmand AI links 87 papers to Dr. Feuerstadt, published from 2010 to 2025. 2023 was the busiest year, with 16. The most frequent topics are Clostridium Infections, Clostridioides difficile and Anti-Bacterial Agents. Dr. Feuerstadt has published most often in Am J Gastroenterol. Dr. Feuerstadt's most frequent co-authors are Lawrence J. Brandt, MD, Sahil Khanna, MBBS and Mena Boules, MD.

Dmand AI links Dr. Feuerstadt to 3 clinical trials. Conditions studied include Clostridium Infections, Non-alcoholic Fatty Liver Disease and Rectal Diseases.

CMS Open Payments shows 986 general payments to Dr. Feuerstadt from 44 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 51% of the total. Ferring Pharmaceuticals Inc. paid the most, $485,843.

Dmand AI lists 1 award for Dr. Feuerstadt, most recently CMS Stage 1 2012 in 2012.

Dr. Feuerstadt graduated from Weill Cornell Medicine in 2004. Dr. Feuerstadt is a member of ACG, AGA and ASGE.

Dr. Feuerstadt is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.